Company intelligence / Profile preview

Lisata Therapeutics

Basking Ridge, NJ, United Statesir.lisata.com ↗
Ownership
Public · LSTA
Development stage
Phase 2
01

Overview

Lead candidate certepetide has demonstrated favorable safety, tolerability, and activity in clinical trials as an enhancer of standard-of-care chemotherapy for pancreatic cancer. Multiple ongoing Phase I/II trials are evaluating its ability to improve drug delivery and outcomes in various advanced solid tumor indications. Key data readouts are expected throughout late 2025.[7][8]

Therapeutic areas
Oncology
Modalities
Cyclic peptides (notably certepetide)Drug delivery enhancers for anti-cancer drugs (enabling small molecules, immunotherapies, RNA-based therapeutics)[6][10]
Industry
Biotech
02

Drug pipeline

14 assets

certepetide

2

13 more assets in the full pipeline.

Request access →
03

Partnerships

GATC Health (AI-driven drug development collaboration) [3]Qilu Pharmaceutical Co. Ltd. (China trial partner)various academic collaborations [2]
04

Financials

Market cap
$16.9M
Total revenue
$0
Enterprise value
$6.5M

Beyond the preview

Go deeper on Lisata Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lisata Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call